HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin E can compensate the density of M1 receptors in the hippocampus of scopolamine-treated rats.

Abstract
M1 muscarinic receptor plays a fundamental role in memory and is closely associated with Alzheimer's disease (AD); it has long been assumed as a therapeutic goal. By activating of the cholinergic receptor vitamin E helps with memory retention. But effects of vitamin E on density of M1 muscarinic receptor-immunoreactive (ir) neurons remain poorly understood. The present research aimed to examine the chronic administration effect of vitamin E against scopolamine-induced memory loss and the number of M1 muscarinic receptor-ir neurons of the hippocampus in male rats. Randomly, 42 adult male Wistar rats were divided to six groups: control, Sham-saline: receiving scopolamine + saline, Sham-sesame oil: receiving scopolamine + sesame oil and three experimental groups: receiving scopolamine + vitamin E with different doses (25, 50, and 100 mg/kg/day, i.p.) for 14 days. The passive avoidance task was used for the memory test. Twenty-four hours after behavioral tests, rats' brains were taken and fixed, and after tissue processing, sections were stained using the immunohistochemical technique for M1 muscarinic receptor-ir neurons and cresyl violet for neurons. The injection of scopolamine to rats caused memory impairment and vitamin E treatment could ameliorate it. In the scopolamine-treated groups, the number of CA1 and CA3 pyramidal and dentate gyrus (DG) granular neurons was decreased significantly as compared to the control group. Vitamin E treatment significantly increased neuron numbers in the CA1 and CA3 areas of the hippocampus and DG area. Treatment with vitamin E for 14 days could compensate the loss of M1 muscarinic receptor-immunoreactive neuron numbers induced by scopolamine in the hippocampus. The most effective vitamin E dose was 50 mg/kg/day in this study. In conclusion, vitamin E can compensate the neuronal loss in the hippocampal formation and also it can raise the density of M1 receptor-ir muscarinic neurons after an injection of scopolamine.
AuthorsAli Sayyahi, Mehrdad Jahanshahi, Hossein Amini, Hamid Sepehri
JournalFolia neuropathologica (Folia Neuropathol) Vol. 56 Issue 3 Pg. 215-228 ( 2018) ISSN: 1509-572X [Electronic] Poland
PMID30509043 (Publication Type: Journal Article)
Chemical References
  • Muscarinic Antagonists
  • Neuroprotective Agents
  • Receptor, Muscarinic M1
  • Vitamin E
  • Scopolamine
Topics
  • Animals
  • Avoidance Learning (drug effects)
  • Hippocampus (drug effects, metabolism)
  • Male
  • Muscarinic Antagonists (toxicity)
  • Neuroprotective Agents (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptor, Muscarinic M1 (metabolism)
  • Scopolamine (toxicity)
  • Vitamin E (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: